Renee has served as the Vice President of External Strategy for Genetic Medicines at Eli Lilly and Company, where she played a pivotal role in shaping the scientific direction through numerous successful deals and acquisition. Notably, her recent endeavour in founding Williams Biotech Consulting underscores her commitment to advancing RNA therapeutics and genetic medicines.

 

Her journey spans across various roles, from her early days as a chemist at Janssen to her strategic leadership positions in business development and operations. Her academic background, including dual MBAs and a PhD in Chemistry, reflects her dedication to continuous learning and expertise.